Veterinary Artificial Insemination Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 4.76 Billion |
| Market Size (2029) | USD 6.50 Billion |
| CAGR (2024 - 2029) | 6.45 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Veterinary Artificial Insemination Market Analysis
The Global Veterinary Artificial Insemination Market size is estimated at USD 4.76 billion in 2024, and is expected to reach USD 6.5 billion by 2029, growing at a CAGR of 6.45% during the forecast period (2024-2029).
The COVID-19 pandemic has created a significant adverse impact on different sectors, including the veterinary sectors in several countries. It has caused disruptions in livestock and poultry value chains, leading to a fall in the procurement and sale of animal-sourced food. Animals suffered due to a lack of adequate feed and veterinary care, such as the need for timely artificial insemination, timely pregnancy check, and de-worming. To safeguard farmers and employees against COVID-19, the Animal Husbandry Department of India launched a program in June 2020, which offered telephonic assistance to poultry farmers and owners. Additionally, artificial insemination was delivered to farmers at their doorstep during the COVID-19 pandemic. Therefore, such initiatives have contributed to market growth.
The factors driving the market growth include the growing animal and fishery industry and the increasing burden of sexually transmitted diseases. As per an article titled 'Controlling sexually transmitted diseases in cattle' published in March 2022, sexually transmitted diseases (STDs), such as vibriosis and bovine trichomoniasis (trich), can become a major problem and result in substantial production losses. Hence, protecting farm animals from the spread of sexually transmitted diseases is expected to drive the market. Furthermore, globally, the demand for the superior breed of animals is increasing, which, in turn, is increasing the demand for artificial insemination procedures in animals. Additionally, globally, the rising human population and associated advantages, such as decreased cost of housing, increased efficiency of bull usage, safety for farmers and animals, genetic selection, and handling of bulls, are anticipated to drive market growth in the future.
The artificial insemination technique helps reduce many of the transmitted diseases among veterinary animals. It allows greater efficiency in terms of genetics and crossbreeding of animals. As per an article titled 'Success rate of artificial insemination, reproductive performance and economic impact of the failure of first service insemination: a retrospective study' published in June 2022, artificial insemination (AI) is recognized as the best technique for increasing reproductive capacity and has received a widespread application in farm animals in Ethiopia. The success of AI is also influenced by endometrial thickness, artifcial insemination timing, insemination frequency, and ovarian stimulation protocols. This is expected to increase the demand for artificial insemination (AI) and drive market growth in the forecast period.
Furthermore, as per the Food and Agriculture Organization of the United Nations, October 2021, approximately 50% of the world's population consumes fish as food, which is driving the need for larger production of animals. Therefore, this is expected to boost the demand for veterinary artificial insemination.
However, the high cost of equipment and procedures is expected to restrain the market growth during the forecast period.
Veterinary Artificial Insemination Market Trends
This section covers the major market trends shaping the Veterinary Artificial Insemination Market according to our research experts:
The Veterinary Hospital Segment is Expected to Gain a Significant Market Share in the Veterinary Artificial Insemination Market
The veterinary hospital segment is expected to witness significant growth in the market, owing to the rising livestock population, higher prevalence of transmitting diseases, and increasing artificial insemination techniques. In India, Animal Husbandry Department launched a program to safeguard its employees and farmers against COVID-19. The veterinary hospitals provided artificial insemination services during the COVID-19 pandemic with preventive measures, such as gloves, masks, sanitizers, and floor cleaners, to maintain the optimal level of hygiene. In the United States, ABC Veterinary Hospital provided artificial insemination services by keeping staff and pet parents safe during the COVID-19 outbreak and implemented new procedures to prevent COVID-19 infection.
Globally, an increasing number of hospitals performing artificial insemination techniques and a rising number of veterinarians are driving the market growth. For instance, as per Animal Husbandry, Dairying and Fisheries Department 2020-2021 report, in India, field institutions of the department provided breeding services to the cattle population. Furthermore, an artificial insemination service was provided for cattle and buffaloes at the cost of INR 10 per insemination. A total of 48.88 lakh artificial inseminations were performed during the 2019-2020 period.
Furthermore, animals that are in close contact or share the same environment may result in the spreading of infectious diseases. For instance, in 2019, South Korea discovered its first outbreak of deadly African swine fever (ASF) at a pig farm in Paju, Gyeonggi Province, South Korea. Thus, livestock diseases are also contributing to a set of problems within livestock production systems. These problems include productivity losses, uncertain food security, and loss of income, among others, which are adversely affecting human health. Hence, in order to prevent infectious diseases, it is expected to raise demand for artificial insemination in the coming years.
Therefore, these factors are expected to drive the need for artificial mating and positively influence the veterinary artificial insemination market.
Asia-Pacific is Expected to Witness a Significant Growth in the Market During the Forecast Period
The major factors driving the veterinary artificial insemination market growth in the Asia-Pacific region include growing infectious diseases in animals and increasing awareness about artificial insemination among people. In Asia, countries, like India, China, and South Korea, are severely affected due to the COVID-19 outbreak. During the COVID-19 pandemic, in May 2020, in India, the National Dairy Development Board (NDDB) launched an interactive webinar to create awareness about procedures to be followed in the dairy value chain during the COVID-19 pandemic. Additionally, artificial insemination and breeding management, difficulties faced by co-operatives, and ensured regular payments to farmers have boosted the market growth.
Avian influenza is a highly contagious viral disease affecting several species of food-producing birds, such as chickens, quails, and pet birds. For instance, as per the World Organisation for Animal Health, key facts data updated in 2021, in Asia countries, Avian influenza continues to cause severe losses in poultry. Moreover, there is a rising in the adoption of artificial insemination to reduce the risk of infectious disease transmission among veterinary animals.
According to a research article by M A Hannan et al., published in the Journal of Veterinary Medical Science in February 2019, embryo transfer in Japan by artificial insemination using frozen semen was found to be useful in improving the productivity of Japanese domestic and special riding horses. As per Animal Husbandry, Dairying and Fisheries Department 2020-2021 report, in India, the department introduced the new technology of sexing the semen by which the sperm responsible for the birth of male calves are sorted and eliminated, and as a consequence, only female calves are produced. Additionally, the government has proposed to adopt new technology by using 2,000 numbers of such semen doses, which may be used for artificial insemination in the farmer's animals on a pilot basis. For instance, in August 2019, Obstetrics of Madras Veterinary College and the Department of Veterinary, Gynecology started artificial insemination in cattle using sexed semen. Hence, the factors mentioned above are expected to fuel the market growth in the region.
Veterinary Artificial Insemination Industry Overview
The veterinary artificial insemination market is moderately competitive, with the presence of both international and local companies. Some of the companies in the veterinary artificial insemination market are IMV Technologies, Neogen Corporation, Bovine Elite LLC, Agtech Inc., and Zoetis Inc., among others.
Veterinary Artificial Insemination Market Leaders
IMV Technologies
Neogen Corporation
Bovine ELite LLC
Agtech Inc.
Zoetis Inc.
*Disclaimer: Major Players sorted in no particular order
Veterinary Artificial Insemination Market News
- In April 2022, Over 400 mobile veterinary units have been approved by the central government for the over 4.6 crore livestock of Madhya Pradesh, India. Each vehicle will have a veterinarian, a paravet, and a vehicle driver-cum-assistant. It will have equipment related to veterinary, minor surgery, and artificial insemination among other facilities
- In August 2020, Cogent collaborated with AB Europe, a sheep breeding company, to launch a novel sexed semen service for sheep producers in the United Kingdom.
Veterinary Artificial Insemination Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Animal Husbandry and Fishery Industry
4.2.2 Increasing Burden of Venereal Diseases in Animals
4.3 Market Restraints
4.3.1 High Cost of Equipment
4.4 Industry Attractiveness - Porter's Five Forces Analysis
4.4.1 Bargaining Power of Buyers/Consumers
4.4.2 Bargaining Power of Suppliers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Equipment
5.1.2 Reagents and Kits
5.1.3 Other Product Types
5.2 By End User
5.2.1 Veterinary Hospitals
5.2.2 Veterinary Clinics
5.2.3 Other End Users
5.3 By Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bovine Elite LLC
6.1.2 KRUUSE
6.1.3 Agtech Inc.
6.1.4 IMV Technologies
6.1.5 Tek-Event
6.1.6 Zoetis Inc.
6.1.7 Neogen Corporation
6.1.8 Iherdsman
6.1.9 Swine Genetics International
6.1.10 Select Sires Inc.
6.1.11 GENEX Cooperative
6.1.12 Genus PLC (ABS Global)
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Veterinary Artificial Insemination Industry Segmentation
As per the scope of the report, artificial insemination is a technique of breeding animals through frozen straws with the help of various equipment and reagents. The veterinary artificial insemination market is segmented by product type (equipment, reagents and kits, and other product types), end user (veterinary hospitals, veterinary clinics, and other end users), and geography (North America, Europe, Asia Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.
| By Product Type | |
| Equipment | |
| Reagents and Kits | |
| Other Product Types |
| By End User | |
| Veterinary Hospitals | |
| Veterinary Clinics | |
| Other End Users |
| By Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Veterinary Artificial Insemination Market Research FAQs
How big is the Global Veterinary Artificial Insemination Market?
The Global Veterinary Artificial Insemination Market size is expected to reach USD 4.76 billion in 2024 and grow at a CAGR of 6.45% to reach USD 6.50 billion by 2029.
What is the current Global Veterinary Artificial Insemination Market size?
In 2024, the Global Veterinary Artificial Insemination Market size is expected to reach USD 4.76 billion.
Who are the key players in Global Veterinary Artificial Insemination Market?
IMV Technologies, Neogen Corporation, Bovine ELite LLC, Agtech Inc. and Zoetis Inc. are the major companies operating in the Global Veterinary Artificial Insemination Market.
Which is the fastest growing region in Global Veterinary Artificial Insemination Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Veterinary Artificial Insemination Market?
In 2024, the North America accounts for the largest market share in Global Veterinary Artificial Insemination Market.
What years does this Global Veterinary Artificial Insemination Market cover, and what was the market size in 2023?
In 2023, the Global Veterinary Artificial Insemination Market size was estimated at USD 4.47 billion. The report covers the Global Veterinary Artificial Insemination Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Veterinary Artificial Insemination Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Global Veterinary Artificial Insemination Industry Report
Statistics for the 2024 Global Veterinary Artificial Insemination market share, size and revenue growth rate, created by Mordor Intelligenceā¢ Industry Reports. Global Veterinary Artificial Insemination analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
